BioCentury
ARTICLE | Company News

Oxxon, Bavarian Nordic A/, Danisco, Novartis, Oxford BioMedica, sanofi-aventis, Therion infectious news

October 9, 2006 7:00 AM UTC

Oxxon said the Opposition Division of the European Patent Office (EPO) narrowed the claims of Oxxon's European Patent No. EPO979284 in an opposition that was brought by BAVA, SAN, OXB, Therion, Danisc...